The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where David Boettiger sits on this spectrum.
This scientist: 161 publications — 32nd percentile
32% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where David Boettiger sits on this spectrum.
This scientist: 54 D-Index — 22nd percentile
22% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
David Boettiger is a researcher affiliated with the University of Pennsylvania in the United States. Their work spans several interconnected fields within the biomedical sciences, particularly focusing on medicine and biochemistry, genetics, and molecular biology. The main areas of study that emerge from their publications include epidemiology, molecular biology, immunology and allergy, cancer research, and modeling and simulation.
Boettiger's research contributions are reflected in diverse scientific topics. Key themes include:
Their publication record features works in notable scientific journals such as Vaccine and the Journal of Cell Science. Selected recent papers include:
Boettiger often collaborates with a range of coauthors, indicating engagement with a wider scientific community. Frequent coauthors include Anthony T. Newall, Allen L. Nazareno, David Muscatello, Cécile Viboud, and Lone Simonsen. This highlights their active participation in multidisciplinary research teams.
Their expertise is applied to understanding complex biological mechanisms such as NF-κB signaling pathways, which are critical in cell survival and immune responses. Additionally, the research addresses public health concerns through epidemiological studies on influenza and respiratory infections, including vaccine uptake and its impact on mortality.
Boettiger's scope of research covers translational topics bridging molecular biology with clinical and population health, reflecting a comprehensive approach to studying infectious diseases and cellular signaling processes.
Matthew J. Paszek;Nastaran Zahir;Kandice R. Johnson;Johnathon N. Lakins
Julie C. Friedland;Mark H. Lee;David Boettiger
Andrés J. Garcı́a;Marı́a D. Vega;David Boettiger
A S Menko;D Boettiger
Patrick T. Caswell;May Chan;Andrew J. Lindsay;Mary W. McCaffrey
Matthew J. Paszek;David Boettiger;Valerie M. Weaver;Daniel A. Hammer
Andrés J Garcı́a;David Boettiger
Andrés J. García;Paul Ducheyne;David Boettiger
Maurizio Pacifici;David Boettiger;Kate Roby;Howard Holtzer
Andrés J. García;Paul Ducheyne;David Boettiger
Mark H. Lee;Paul Ducheyne;Laura Lynch;David Boettiger
Andrés J. Garcı́a;François Huber;David Boettiger
Andrés J. García;Jean E. Schwarzbauer;David Boettiger
Qi Shi;David Boettiger
Motomi Enomoto;Phoebe S. Leboy;A.Sue Menko;David Boettiger
Motomi Enomoto-Iwamoto;Masahiro Iwamoto;Kazuhisa Nakashima;Yoshiki Mukudai
Sherrill L. Adams;David Boettiger;Richard J. Focht;Howard Holtzer
Kate Roby;John Brumbaugh;Judy Biehl;Howard Holtzer
Andrés J. Garcı́a;Junichi Takagi;David Boettiger
Kyle R Legate;Seiichiro Takahashi;Navid Bonakdar;Ben Fabry
If you think any of the details on this page are incorrect, let us know.
University of Copenhagen
Universidade Federal de Viçosa
Brock University
North Carolina State University
National Institutes of Health
University of Maryland, College Park
Hangzhou Normal University
Mayo Clinic
York University
University of Cologne
University of Copenhagen
Henry Ford Health System
Northwestern University
Cornell University
Stanford University
University of Calgary